Back to Search Start Over

Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: Systematic review and meta-analysis of 14 015 stroke cases and pooled analysis of primary biomarker data from up to 60 883 individuals.

Authors :
Khan, Tauseef A
Shah, Tina
Prieto, David
Zhang, Weili
Price, Jackie
Fowkes, Gerald R
Cooper, Jackie
Talmud, Philippa J
Humphries, Steve E
Sundstrom, Johan
Hubacek, Jaroslav A
Ebrahim, Shah
Lawlor, Debbie A
Ben-Shlomo, Yoav
Abdollahi, Mohammad R
Slooter, Arjen JC
Szolnoki, Zoltan
Sandhu, Manjinder
Wareham, Nicholas
Frikke-Schmidt, Ruth
Source :
International Journal of Epidemiology; Apr2013, Vol. 42 Issue 2, p475-492, 18p
Publication Year :
2013

Abstract

Background At the APOE gene, encoding apolipoprotein E, genotypes of the ϵ2/ϵ3/ϵ4 alleles associated with higher LDL-cholesterol (LDL-C) levels are also associated with higher coronary risk. However, the association of APOE genotype with other cardiovascular biomarkers and risk of ischaemic stroke is less clear. We evaluated the association of APOE genotype with risk of ischaemic stroke and assessed whether the observed effect was consistent with the effects of APOE genotype on LDL-C or other lipids and biomarkers of cardiovascular risk.Methods We conducted a systematic review of published and unpublished studies reporting on APOE genotype and ischaemic stroke. We pooled 41 studies (with a total of 9027 cases and 61 730 controls) using a Bayesian meta-analysis to calculate the odds ratios (ORs) for ischaemic stroke with APOE genotype. To better evaluate potential mechanisms for any observed effect, we also conducted a pooled analysis of primary data using 16 studies (up to 60 883 individuals) of European ancestry. We evaluated the association of APOE genotype with lipids, other circulating biomarkers of cardiovascular risk and carotid intima-media thickness (C-IMT).Results The ORs for association of APOE genotypes with ischaemic stroke were: 1.09 (95% credible intervals (CrI): 0.84–1.43) for ϵ2/ϵ2; 0.85 (95% CrI: 0.78–0.92) for ϵ2/ϵ3; 1.05 (95% CrI: 0.89–1.24) for ϵ2/ϵ4; 1.05 (95% CrI: 0.99–1.12) for ϵ3/ϵ4; and 1.12 (95% CrI: 0.94–1.33) for ϵ4/ϵ4 using the ϵ3/ϵ3 genotype as the reference group. A regression analysis that investigated the effect of LDL-C (using APOE as the instrument) on ischaemic stroke showed a positive dose-response association with an OR of 1.33 (95% CrI: 1.17, 1.52) per 1 mmol/l increase in LDL-C. In the separate pooled analysis, APOE genotype was linearly and positively associated with levels of LDL-C (P-trend: 2 × 10−152), apolipoprotein B (P-trend: 8.7 × 10−06) and C-IMT (P-trend: 0.001), and negatively and linearly associated with apolipoprotein E (P-trend: 6 × 10−26) and HDL-C (P-trend: 1.6 × 10−12). Associations with lipoprotein(a), C-reactive protein and triglycerides were non-linear.Conclusions In people of European ancestry, APOE genotype showed a positive dose-response association with LDL-C, C-IMT and ischaemic stroke. However, the association of APOE ϵ2/ϵ2 genotype with ischaemic stroke requires further investigation. This cross-domain concordance supports a causal role of LDL-C on ischaemic stroke. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03005771
Volume :
42
Issue :
2
Database :
Complementary Index
Journal :
International Journal of Epidemiology
Publication Type :
Academic Journal
Accession number :
86865728
Full Text :
https://doi.org/10.1093/ije/dyt034